A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia

Keyphrases

• Aerosolized 20%
• AIDS/HIV 60%
• Alternative Drugs 20%
• Antiviral Drugs 20%
• Atovaquone 40%
• Case-case 20%
• Clindamycin 40%
• Clindamycin Phosphate 20%
• Clinical Drug Trials 20%
• Clinical Outcomes 20%
• Combination Products 40%
• Corticosteroid Drugs 20%
• Dapsone 40%
• Drug Therapy 20%
• Drug Treatment 20%
• Drug Treatment Outcomes 20%
• Effective Alternatives 20%
• Eflornithine Hydrochloride 20%
• HIV-infected Patients 20%
• Meta-analysis 100%
• Pentamidine 100%
• Pneumocystis Jirovecii 100%
• Pneumonia 60%
• Primaquine 40%
• Primaquine Phosphate 20%
• Relative Efficacy 20%
• Salvage Regimen 40%
• Salvage Therapy 100%
• Sulfamethoxazole 20%
• Systemic Corticosteroids 20%
• Trimethoprim 40%
• Trimethoprim-sulfamethoxazole (TMP-SMX) 80%
• Trimetrexate 20%
• Underlying Disease 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Acquired Immune Deficiency Syndrome 20%
• Atovaquone 40%
• Clindamycin 40%
• Clindamycin Phosphate 20%
• Cotrimoxazole 100%
• Dapsone 40%
• Diseases 20%
• Drug Screening 20%
• Eflornithine 20%
• HIV 40%
• Pentamidine 100%
• Pharmacotherapy 40%
• Pneumocystis Pneumonia 100%
• Pneumonia 60%
• Primaquine 60%
• Relative Efficacy 20%
• Trimethoprim 20%
• Trimetrexate 20%